{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:26:39Z","timestamp":1792715199542,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,3,29]],"date-time":"2009-03-29T00:00:00Z","timestamp":1238284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1038\/nm.1945","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T18:52:07Z","timestamp":1238439127000},"page":"417-424","source":"Crossref","is-referenced-by-count":191,"title":["Estrogen-dependent and C-C chemokine receptor-2\u2013dependent pathways determine osteoclast behavior in osteoporosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Nikolaus B","family":"Binder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Niederreiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Stange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M","family":"Stulnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold G","family":"Erben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef S","family":"Smolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Redlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,29]]},"reference":[{"key":"BFnm1945_CR1","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","volume":"289","author":"SL Teitelbaum","year":"2000","unstructured":"Teitelbaum, S.L. Bone resorption by osteoclasts. Science 289, 1504\u20131508 (2000).","journal-title":"Science"},{"key":"BFnm1945_CR2","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1172\/JCI28550","volume":"116","author":"MN Weitzmann","year":"2006","unstructured":"Weitzmann, M.N. & Pacifici, R. Estrogen deficiency and bone loss: an inflammatory tale. J. Clin. Invest. 116, 1186\u20131194 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnm1945_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2302\/kjm.52.1","volume":"52","author":"T Miyamoto","year":"2003","unstructured":"Miyamoto, T. & Suda, T. Differentiation and function of osteoclasts. Keio J. Med. 52, 1\u20137 (2003).","journal-title":"Keio J. Med."},{"key":"BFnm1945_CR4","first-page":"225","volume":"37","author":"JJ Stepan","year":"2003","unstructured":"Stepan, J.J., Alenfeld, F., Boivin, G., Feyen, J.H. & Lakatos, P. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis. Endocr. Regul. 37, 225\u2013238 (2003).","journal-title":"Endocr. Regul."},{"key":"BFnm1945_CR5","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1056\/NEJMra040952","volume":"351","author":"J Tolar","year":"2004","unstructured":"Tolar, J., Teitelbaum, S.L. & Orchard, P.J. Osteopetrosis. N. Engl. J. Med. 351, 2839\u20132849 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1945_CR6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood.V96.2.671","volume":"96","author":"SJ Choi","year":"2000","unstructured":"Choi, S.J. et al. Macrophage inflammatory protein 1-\u03b1 is a potential osteoclast stimulatory factor in multiple myeloma. Blood 96, 671\u2013675 (2000).","journal-title":"Blood"},{"key":"BFnm1945_CR7","doi-asserted-by":"publisher","first-page":"16163","DOI":"10.1074\/jbc.M412713200","volume":"280","author":"MS Kim","year":"2005","unstructured":"Kim, M.S., Day, C.J. & Morrison, N.A. MCP-1 is induced by receptor activator of nuclear factor-\u03baB ligand, promotes human osteoclast fusion and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J. Biol. Chem. 280, 16163\u201316169 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnm1945_CR8","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1074\/jbc.M510156200","volume":"281","author":"MS Kim","year":"2006","unstructured":"Kim, M.S. et al. MCP-1\u2013induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NF\u03baB ligand for bone resorption. J. Biol. Chem. 281, 1274\u20131285 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnm1945_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S1359-6101(01)00014-4","volume":"12","author":"R Horuk","year":"2001","unstructured":"Horuk, R. Chemokine receptors. Cytokine Growth Factor Rev. 12, 313\u2013335 (2001).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnm1945_CR10","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1172\/JCI119798","volume":"100","author":"L Boring","year":"1997","unstructured":"Boring, L. et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100, 2552\u20132561 (1997).","journal-title":"J. Clin. Invest."},{"key":"BFnm1945_CR11","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1073\/pnas.91.7.2752","volume":"91","author":"IF Charo","year":"1994","unstructured":"Charo, I.F. et al. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl. Acad. Sci. USA 91, 2752\u20132756 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1945_CR12","doi-asserted-by":"publisher","first-page":"6846","DOI":"10.4049\/jimmunol.180.10.6846","volume":"180","author":"T Jia","year":"2008","unstructured":"Jia, T. et al. Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection. J. Immunol. 180, 6846\u20136853 (2008).","journal-title":"J. Immunol."},{"key":"BFnm1945_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jcb.20649","volume":"97","author":"MS Kim","year":"2006","unstructured":"Kim, M.S., Magno, C.L., Day, C.J. & Morrison, N.A. Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES. J. Cell. Biochem. 97, 512\u2013518 (2006).","journal-title":"J. Cell. Biochem."},{"key":"BFnm1945_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF00441848","volume":"145","author":"K Kruse","year":"1986","unstructured":"Kruse, K. & Kracht, U. Evaluation of serum osteocalcin as an index of altered bone metabolism. Eur. J. Pediatr. 145, 27\u201333 (1986).","journal-title":"Eur. J. Pediatr."},{"key":"BFnm1945_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0221-8747(81)90041-2","volume":"3","author":"RG Russell","year":"1981","unstructured":"Russell, R.G. et al. Biochemical markers of bone turnover in Paget's disease. Metab. Bone Dis. Relat. Res. 3, 255\u2013262 (1981).","journal-title":"Metab. Bone Dis. Relat. Res."},{"key":"BFnm1945_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey, D.L. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165\u2013176 (1998).","journal-title":"Cell"},{"key":"BFnm1945_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/art.11419","volume":"50","author":"P Li","year":"2004","unstructured":"Li, P. et al. Systemic tumor necrosis factor \u03b1 mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor \u03b1\u2013transgenic mice. Arthritis Rheum. 50, 265\u2013276 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnm1945_CR18","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1172\/JCI29919","volume":"117","author":"CL Tsou","year":"2007","unstructured":"Tsou, C.L. et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117, 902\u2013909 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnm1945_CR19","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/01.ATV.0000019009.73586.7F","volume":"22","author":"C Viedt","year":"2002","unstructured":"Viedt, C. et al. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-\u03baB and activator protein-1. Arterioscler. Thromb. Vasc. Biol. 22, 914\u2013920 (2002).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnm1945_CR20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nm1255","volume":"11","author":"AI Idris","year":"2005","unstructured":"Idris, A.I. et al. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat. Med. 11, 774\u2013779 (2005).","journal-title":"Nat. Med."},{"key":"BFnm1945_CR21","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1210\/endo-122-3-1146","volume":"122","author":"RT Turner","year":"1988","unstructured":"Turner, R.T., Wakley, G.K., Hannon, K.S. & Bell, N.H. Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats. Endocrinology 122, 1146\u20131150 (1988).","journal-title":"Endocrinology"},{"key":"BFnm1945_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cellimm.2005.08.032","volume":"235","author":"JL Owen","year":"2005","unstructured":"Owen, J.L. et al. The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor-derived factors. Cell. Immunol. 235, 122\u2013135 (2005).","journal-title":"Cell. Immunol."},{"key":"BFnm1945_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1196\/annals.1346.019","volume":"1068","author":"A Zallone","year":"2006","unstructured":"Zallone, A. Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann. N.Y. Acad. Sci. 1068, 173\u2013179 (2006).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"BFnm1945_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF00296282","volume":"50","author":"SC Manolagas","year":"1992","unstructured":"Manolagas, S.C. & Jilka, R.L. Cytokines, hematopoiesis, osteoclastogenesis and estrogens. Calcif. Tissue Int. 50, 199\u2013202 (1992).","journal-title":"Calcif. Tissue Int."},{"key":"BFnm1945_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1210\/rp.57.1.385","volume":"57","author":"SC Manolagas","year":"2002","unstructured":"Manolagas, S.C., Kousteni, S. & Jilka, R.L. Sex steroids and bone. Recent Prog. Horm. Res. 57, 385\u2013409 (2002).","journal-title":"Recent Prog. Horm. Res."},{"key":"BFnm1945_CR26","doi-asserted-by":"publisher","first-page":"63S","DOI":"10.1016\/8756-3282(95)00180-L","volume":"17","author":"SC Manolagas","year":"1995","unstructured":"Manolagas, S.C. Role of cytokines in bone resorption. Bone 17, 63S\u201367S (1995).","journal-title":"Bone"},{"key":"BFnm1945_CR27","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1172\/JCI11066","volume":"106","author":"S Cenci","year":"2000","unstructured":"Cenci, S. et al. Estrogen deficiency induces bone loss by enhancing T cell production of TNF-\u03b1. J. Clin. Invest. 106, 1229\u20131237 (2000).","journal-title":"J. Clin. Invest."},{"key":"BFnm1945_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1172\/JCI200523394","volume":"115","author":"S Wei","year":"2005","unstructured":"Wei, S., Kitaura, H., Zhou, P., Ross, F.P. & Teitelbaum, S.L. IL-1 mediates TNF-induced osteoclastogenesis. J. Clin. Invest. 115, 282\u2013290 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnm1945_CR29","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/jcb.10319","volume":"87","author":"JM Lean","year":"2002","unstructured":"Lean, J.M., Murphy, C., Fuller, K. & Chambers, T.J. CCL9\/MIP-1\u03b3 and its receptor CCR1 are the major chemokine ligand\/receptor species expressed by osteoclasts. J. Cell. Biochem. 87, 386\u2013393 (2002).","journal-title":"J. Cell. Biochem."},{"key":"BFnm1945_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2141.2007.06747.x","volume":"139","author":"I Breitkreutz","year":"2007","unstructured":"Breitkreutz, I. et al. Targeting MEK1\/2 blocks osteoclast differentiation, function and cytokine secretion in multiple myeloma. Br. J. Haematol. 139, 55\u201363 (2007).","journal-title":"Br. J. Haematol."},{"key":"BFnm1945_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1046\/j.8755-8920.2003.00117.x","volume":"51","author":"K Janis","year":"2004","unstructured":"Janis, K. et al. Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes. Am. J. Reprod. Immunol. 51, 22\u201331 (2004).","journal-title":"Am. J. Reprod. Immunol."},{"key":"BFnm1945_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1095\/biolreprod61.1.85","volume":"61","author":"A Arici","year":"1999","unstructured":"Arici, A., Senturk, L.M., Seli, E., Bahtiyar, M.O. & Kim, G. Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by estrogen and progesterone. Biol. Reprod. 61, 85\u201390 (1999).","journal-title":"Biol. Reprod."},{"key":"BFnm1945_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0167-5273(01)00527-7","volume":"81","author":"KK Koh","year":"2001","unstructured":"Koh, K.K. et al. Effect of hormone replacement therapy on nitric oxide bioactivity and monocyte chemoattractant protein-1 levels. Int. J. Cardiol. 81, 43\u201350 (2001).","journal-title":"Int. J. Cardiol."},{"key":"BFnm1945_CR34","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1056\/NEJMoa044459","volume":"354","author":"MR McClung","year":"2006","unstructured":"McClung, M.R. et al. Denosumab in postmenopausal women with low bone mineral density. N. Engl. J. Med. 354, 821\u2013831 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1945_CR35","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","volume":"13","author":"WC Dougall","year":"1999","unstructured":"Dougall, W.C. et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 13, 2412\u20132424 (1999).","journal-title":"Genes Dev."},{"key":"BFnm1945_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"YY Kong","year":"1999","unstructured":"Kong, Y.Y. et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315\u2013323 (1999).","journal-title":"Nature"},{"key":"BFnm1945_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1006\/geno.2002.6793","volume":"80","author":"Y Yamada","year":"2002","unstructured":"Yamada, Y., Ando, F., Niino, N. & Shimokata, H. Association of a polymorphism of the CC chemokine receptor-2 gene with bone mineral density. Genomics 80, 8\u201312 (2002).","journal-title":"Genomics"},{"key":"BFnm1945_CR38","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1084\/jem.20040852","volume":"201","author":"S Hayer","year":"2005","unstructured":"Hayer, S. et al. CD44 is a determinant of inflammatory bone loss. J. Exp. Med. 201, 903\u2013914 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnm1945_CR39","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt, A.M. et al. Bone histomorphometry: standardization of nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2, 595\u2013610 (1987).","journal-title":"J. Bone Miner. Res."},{"key":"BFnm1945_CR40","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1359\/jbmr.2000.15.8.1477","volume":"15","author":"S Takeshita","year":"2000","unstructured":"Takeshita, S., Kaji, K. & Kudo, A. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J. Bone Miner. Res. 15, 1477\u20131488 (2000).","journal-title":"J. Bone Miner. Res."},{"key":"BFnm1945_CR41","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/nm752","volume":"8","author":"S Takeshita","year":"2002","unstructured":"Takeshita, S. et al. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat. Med. 8, 943\u2013949 (2002).","journal-title":"Nat. Med."},{"key":"BFnm1945_CR42","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1046\/j.1365-2141.1999.01203.x","volume":"104","author":"O Herault","year":"1999","unstructured":"Herault, O. et al. A rapid single-laser flow cytometric method for discrimination of early apoptotic cells in a heterogenous cell population. Br. J. Haematol. 104, 530\u2013537 (1999).","journal-title":"Br. J. Haematol."},{"key":"BFnm1945_CR43","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0002-9440(10)63144-6","volume":"164","author":"K Redlich","year":"2004","unstructured":"Redlich, K. et al. Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor\u2013mediated arthritis. Am. J. Pathol. 164, 543\u2013555 (2004).","journal-title":"Am. J. Pathol."},{"key":"BFnm1945_CR44","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.4049\/jimmunol.166.7.4697","volume":"166","author":"M Mack","year":"2001","unstructured":"Mack, M. et al. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166, 4697\u20134704 (2001).","journal-title":"J. Immunol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.1945.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.1945","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.1945.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:23:29Z","timestamp":1684448609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.1945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,29]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["BFnm1945"],"URL":"https:\/\/doi.org\/10.1038\/nm.1945","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,29]]}}}